Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies

A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies

(2015) Edward Rockenstein et al.   PLoS One

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure

(2014) Edward Rockenstein et al.   BMC NEUROSCIENCE

Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling

(2014) Kerstin Hartwig et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

Physiological and pathological phosphorylation of tau by Cdk5

(2014) Taeko Kimura et al.   Frontiers in Molecular Neuroscience

Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies

(2013) Elvira Valera et al.   PHARMACOLOGY & THERAPEUTICS

Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

(2012) Kiren Ubhi et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium

(2012) G. G. Kovacs et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Increased CDK5 Expression in HIV Encephalitis Contributes to Neurodegeneration via Tau Phosphorylation and Is Reversed with Roscovitine

(2011) Christina Patrick et al.   AMERICAN JOURNAL OF PATHOLOGY

Immunotherapy for Tauopathies

(2011) Jiaping Gu et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)

(2011) Dennis W. Dickson et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

(2011) Eliezer Masliah et al.   PLoS One

Recent advances in the development of immunotherapies for tauopathies

(2010) Kiren Ubhi et al.   EXPERIMENTAL NEUROLOGY

Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin

(2009) Kiren Ubhi et al.   ACTA NEUROPATHOLOGICA

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease

(2009) Cassia R. Overk et al.   NEUROBIOLOGY OF DISEASE